1st Quarter - Report
BGR GOVERNMENT AFFAIRS for CATALYST PHARMACEUTICALS
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Provide strategic guidance and advocacy regarding legislation and regulations related to the Orphan Drug Act generally and Catalyst Pharmaceuticals specifically
| Lobbyist | Covered position, as disclosed |
|---|---|
| REMY LEIGH BRIM MASON | Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.